An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 16, Issue 6, Pages 711-722
Publisher
Informa UK Limited
Online
2016-05-03
DOI
10.1080/14737175.2016.1179112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer
- (2016) William J. Marks et al. HUMAN GENE THERAPY
- A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
- (2016) Dante J. Marciani JOURNAL OF NEUROCHEMISTRY
- A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease
- (2016) Chi-Jing Choong et al. NEUROBIOLOGY OF AGING
- The genetics of Parkinson's disease
- (2015) Stephen Mullin et al. BRITISH MEDICAL BULLETIN
- SnapShot: Genetics of Parkinson’s Disease
- (2015) José Brás et al. CELL
- Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson’s Disease
- (2015) Penelope J. Hallett et al. Cell Stem Cell
- Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease
- (2015) Hany E.S. Marei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hepatitis C virus infection: a risk factor for Parkinson's disease
- (2015) W. Y.-Y. Wu et al. JOURNAL OF VIRAL HEPATITIS
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
- (2015) Jennifer T. Lamberts et al. NEUROBIOLOGY OF DISEASE
- The association between infectious burden and Parkinson's disease: A case-control study
- (2015) Xian-Le Bu et al. PARKINSONISM & RELATED DISORDERS
- Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
- (2015) Chun-Hyung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases
- (2015) Ting Shen et al. Neuroscience Bulletin
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects
- (2014) Christina E. Khodr et al. BRAIN RESEARCH
- Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
- (2014) Ursula Unterberger et al. CLINICAL NEUROPATHOLOGY
- Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
- (2014) Chou Chai et al. CURRENT GENOMICS
- Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease
- (2014) Tiago Martins Rodrigues et al. DRUGS & AGING
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Direct Conversion of Human Fibroblasts into Neuronal Restricted Progenitors
- (2014) Qingjian Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
- (2014) Jing L Guo et al. NATURE MEDICINE
- Direct conversion of mouse fibroblasts into induced neural stem cells
- (2014) Sung Min Kim et al. Nature Protocols
- The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse
- (2014) Mari H. Savolainen et al. NEUROBIOLOGY OF DISEASE
- Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
- (2014) Gabor G. Kovacs et al. NEUROBIOLOGY OF DISEASE
- Correction: Scale Determinants of Fiscal Investment in Geological Exploration: Evidence from China
- (2014) Linna Lu et al. PLoS One
- Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
- (2014) Gergely Tóth et al. PLoS One
- Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations
- (2014) Vinay K. Godena et al. Nature Communications
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease
- (2013) A.R. Esteves et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
- (2013) Goran Laćan et al. JOURNAL OF NEUROSCIENCE RESEARCH
- NURR1 in Parkinson disease—from pathogenesis to therapeutic potential
- (2013) Mickael Decressac et al. Nature Reviews Neurology
- Gene-based Therapies in Parkinson’s Disease
- (2013) Patricia J. Allen et al. Neurotherapeutics
- Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey Model
- (2013) Min Yan et al. PLoS One
- S-nitrosylation regulates mitochondrial quality control via activation of parkin
- (2013) Kentaro Ozawa et al. Scientific Reports
- Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate Brain
- (2013) Marina E. Emborg et al. Cell Reports
- Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease
- (2013) Zinovia Kefalopoulou et al. JAMA Neurology
- The prion hypothesis in Parkinson's disease: Braak to the future
- (2013) Naomi P Visanji et al. Acta Neuropathologica Communications
- Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models
- (2012) Thomas Kramer et al. ACS Chemical Neuroscience
- A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
- (2012) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin
- (2012) Almas Siddiqui et al. FREE RADICAL RESEARCH
- Infectious Agents and Neurodegeneration
- (2012) Giovanna De Chiara et al. MOLECULAR NEUROBIOLOGY
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- 70 AFFITOPE® — based vaccines: results from phase I support the further clinical development of AFFITOPE® AD02
- (2012) Achim Schneeberger et al. NEUROBIOLOGY OF AGING
- The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD
- (2012) Pallavi Rane et al. NEUROPHARMACOLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson’s Disease
- (2012) Marcel M. Daadi et al. PLoS One
- Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease
- (2011) Jeremy W. Chambers et al. ACS Chemical Neuroscience
- A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons
- (2011) Ye Han et al. BRAIN RESEARCH
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts
- (2011) Jongpil Kim et al. Cell Stem Cell
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Pathways towards an effective immunotherapy for Parkinson’s disease
- (2011) Jessica AL Hutter-Saunders et al. Expert Review of Neurotherapeutics
- Cell-based therapies for Parkinson’s disease
- (2011) Sean C Dyson et al. Expert Review of Neurotherapeutics
- AFFITOME® technology in neurodegenerative diseases: The doubling advantage
- (2011) Achim Schneeberger et al. Human vaccines & immunotherapeutics
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Immunization strategies for Parkinson's disease
- (2011) Duy Ha et al. PARKINSONISM & RELATED DISORDERS
- Vaccination for Parkinson's disease
- (2011) A. Schneeberger et al. PARKINSONISM & RELATED DISORDERS
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
- (2010) H. S. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
- (2009) Marie A. Bogoyevitch et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
- (2009) Kaoru Saijo et al. CELL
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease
- (2009) Neelam K. Venkataramana et al. Translational Research
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
- (2008) Ivar Mendez et al. NATURE MEDICINE
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?
- (2008) R.J. Phillips et al. NEUROSCIENCE
- Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
- (2007) Dali Yang et al. STEM CELLS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started